Back to results

Gas Transfer on ILA-Activve

Primary Purpose

Hypercapnia

Status

Unknown status

Phase

Not Applicable

Locations

Austria

Study Type

Interventional

Intervention

Change of blood flow or sweep gas flow ( ILA Activve)

About this trial

This is an interventional treatment trial for Hypercapnia

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patient on ILA Activve
Controlled mechanical ventilation
No spontaneous breathing

Exclusion Criteria:

- Pregnancy

Sites / Locations

Dept. of Medicine I, ICU, General Hospital of ViennaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Extracorporeal CO2 elimination by ILA Activve(R)

Arm Description

Outcomes

Primary Outcome Measures

Blood gas analysis

Secondary Outcome Measures

Full Information

NCT ID

NCT01997528

First Posted

November 7, 2013

Last Updated

November 22, 2013

Sponsor

Medical University of Vienna

1. Study Identification

Unique Protocol Identification Number

NCT01997528

Brief Title

Gas Transfer on ILA-Activve

Official Title

Efficiency of Gas Exchange Using a Miniaturized Pump Driven Veno-venous Extracorporeal Gas Exchange Device (ILA-Activve)

Study Type

Interventional

2. Study Status

Record Verification Date

November 2013

Overall Recruitment Status

Unknown status

Study Start Date

November 2013 (undefined)

Primary Completion Date

November 2014 (Anticipated)

Study Completion Date

undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Principal Investigator

Name of the Sponsor

Medical University of Vienna

4. Oversight

Data Monitoring Committee

5. Study Description

Brief Summary

Oxygenatuion and decarboxylation during different settings (steps of blood flow and sweep gas flow) of extracorporeal gas exchange by ILA Activve using a jugular 22French double lumen cannula are measured.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Hypercapnia

7. Study Design

Primary Purpose

Treatment

Study Phase

Not Applicable

Interventional Study Model

Single Group Assignment

Masking

None (Open Label)

Allocation

N/A

Enrollment

10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title

Extracorporeal CO2 elimination by ILA Activve(R)

Arm Type

Experimental

Intervention Type

Device

Intervention Name(s)

Change of blood flow or sweep gas flow ( ILA Activve)

Primary Outcome Measure Information:

Title

Blood gas analysis

Time Frame

Changes after every 15 min. of each setting (13 settings leading to 195 min. altogether)

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Maximum Age & Unit of Time

89 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Patient on ILA Activve Controlled mechanical ventilation No spontaneous breathing Exclusion Criteria: - Pregnancy

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Thomas Staudinger, MD

Organizational Affiliation

Medical University of Vienna

Official's Role

Principal Investigator

Facility Information:

Facility Name

Dept. of Medicine I, ICU, General Hospital of Vienna

City

Vienna

ZIP/Postal Code

1090

Country

Austria

Individual Site Status

Recruiting

Facility Contact:

First Name & Middle Initial & Last Name & Degree

Thomas Staudinger, MD

Phone

+43140400

Ext

4492

thomas.staudinger@meduniwien.ac.at

First Name & Middle Initial & Last Name & Degree

Thomas Staudinger, MD

12. IPD Sharing Statement

Learn more about this trial

Gas Transfer on ILA-Activve

We'll reach out to this number within 24 hrs